Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

Nicardipine Administration Guidelines

Initial Dosing and Titration

  • The American Heart Association recommends starting nicardipine at 5 mg/hr IV infusion and titrating by 2.5 mg/hr every 5-15 minutes to a maximum of 15 mg/hr until desired blood pressure is achieved in patients with acute ischemic stroke and blood pressure >185/110 mm Hg 1, 2, 3
  • The American Stroke Association recommends reducing blood pressure to ≤185/110 mm Hg before administering rtPA, and then maintaining blood pressure at ≤180/105 mm Hg after thrombolytic therapy 1, 2, 3
  • For hypertensive emergencies in pregnancy/pre-eclampsia, start nicardipine at 5 mg/hr and titrate by 2.5 mg/hr every 5-15 minutes to a maximum of 15 mg/hr 5

Pharmacokinetics and Monitoring

  • The European Heart Journal reports that the onset of action of nicardipine is 5-15 minutes, and the duration of action after discontinuation is 30-40 minutes 5
  • The American Heart Association recommends monitoring blood pressure and heart rate continuously during titration, and watching for tachycardia (heart rate typically increases by ~10 beats/minute) 1
  • Intensive monitoring is required for stroke patients receiving thrombolytics, with blood pressure checks every 15 minutes for the first 2 hours, every 30 minutes for the next 6 hours, and every hour for the subsequent 16 hours 1, 4

Adverse Effects and Interactions

  • Common side effects of nicardipine include headache (13% incidence), hypotension (5%), tachycardia (4%), nausea/vomiting (4%), and flushing 1, 4
  • The American Heart Association warns that excessive blood pressure reduction within the first 5-7 days of ischemic stroke is associated with adverse neurological outcomes 4
  • Nicardipine can interact with cimetidine, cyclosporine, and tacrolimus, and caution is advised when using these medications together 4